Global Liquid Biopsy For Cancer Diagnostics Supply, Demand and Key Producers, 2023-2029
The global Liquid Biopsy For Cancer Diagnostics market size is expected to reach $ 8129.3 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
This report studies the global Liquid Biopsy For Cancer Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy For Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy For Cancer Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy For Cancer Diagnostics total market, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Liquid Biopsy For Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Liquid Biopsy For Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation and Bio-Techne Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liquid Biopsy For Cancer Diagnostics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Liquid Biopsy For Cancer Diagnostics Market, By Region:
1. How big is the global Liquid Biopsy For Cancer Diagnostics market?
2. What is the demand of the global Liquid Biopsy For Cancer Diagnostics market?
3. What is the year over year growth of the global Liquid Biopsy For Cancer Diagnostics market?
4. What is the total value of the global Liquid Biopsy For Cancer Diagnostics market?
5. Who are the major players in the global Liquid Biopsy For Cancer Diagnostics market?
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
This report studies the global Liquid Biopsy For Cancer Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy For Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy For Cancer Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy For Cancer Diagnostics total market, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Liquid Biopsy For Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Liquid Biopsy For Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation and Bio-Techne Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liquid Biopsy For Cancer Diagnostics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Liquid Biopsy For Cancer Diagnostics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Test
- Urine Test
- Saliva Test
- Hospital
- Diagnostic Center
- Others
- F. Hoffman La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- The Menarini Group
- Bio-Rad Laboratories Inc.
- QIAGEN Inc.
- Exact Sciences Corporation
- Bio-Techne Corporation
- ArcherDX Inc.
- Neogenomics Laboratories Inc.
- Guardant Health Inc.
- Myriad Genetics Inc.
- Foundation Medicine Inc.
- Amoy Diagnostics Co. Ltd.
- Biocartis Group NV
1. How big is the global Liquid Biopsy For Cancer Diagnostics market?
2. What is the demand of the global Liquid Biopsy For Cancer Diagnostics market?
3. What is the year over year growth of the global Liquid Biopsy For Cancer Diagnostics market?
4. What is the total value of the global Liquid Biopsy For Cancer Diagnostics market?
5. Who are the major players in the global Liquid Biopsy For Cancer Diagnostics market?
1 SUPPLY SUMMARY
1.1 Liquid Biopsy For Cancer Diagnostics Introduction
1.2 World Liquid Biopsy For Cancer Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Liquid Biopsy For Cancer Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.3 China Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.4 Europe Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.5 Japan Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.6 South Korea Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.7 ASEAN Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.8 India Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy For Cancer Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Liquid Biopsy For Cancer Diagnostics Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.2 World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region
2.2.1 World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023)
2.2.2 World Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Region (2024-2029)
2.3 United States Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.4 China Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.5 Europe Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.6 Japan Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.7 South Korea Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.8 ASEAN Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.9 India Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
3 WORLD LIQUID BIOPSY FOR CANCER DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy For Cancer Diagnostics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy For Cancer Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy For Cancer Diagnostics in 2022
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy For Cancer Diagnostics in 2022
3.3 Liquid Biopsy For Cancer Diagnostics Company Evaluation Quadrant
3.4 Liquid Biopsy For Cancer Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy For Cancer Diagnostics Market: Region Footprint
3.4.2 Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
3.4.3 Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Liquid Biopsy For Cancer Diagnostics Companies and Market Share, 2018-2023
4.3.1 United States Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
4.4 China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue and Market Share, 2018-2023
4.4.1 China Based Liquid Biopsy For Cancer Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
4.5 Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy For Cancer Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Test
5.2.2 Urine Test
5.2.3 Saliva Test
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2018-2023)
5.3.2 World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2024-2029)
5.3.3 World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Liquid Biopsy For Cancer Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2023)
6.3.2 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffman La Roche Ltd.
7.1.1 F. Hoffman La Roche Ltd. Details
7.1.2 F. Hoffman La Roche Ltd. Major Business
7.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
7.1.4 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffman La Roche Ltd. Recent Developments/Updates
7.1.6 F. Hoffman La Roche Ltd. Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Details
7.2.2 Thermo Fisher Scientific Inc. Major Business
7.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.2.4 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.3 Agilent Technologies Inc.
7.3.1 Agilent Technologies Inc. Details
7.3.2 Agilent Technologies Inc. Major Business
7.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Agilent Technologies Inc. Recent Developments/Updates
7.3.6 Agilent Technologies Inc. Competitive Strengths & Weaknesses
7.4 Illumina Inc.
7.4.1 Illumina Inc. Details
7.4.2 Illumina Inc. Major Business
7.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.4.4 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Illumina Inc. Recent Developments/Updates
7.4.6 Illumina Inc. Competitive Strengths & Weaknesses
7.5 The Menarini Group
7.5.1 The Menarini Group Details
7.5.2 The Menarini Group Major Business
7.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Services
7.5.4 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 The Menarini Group Recent Developments/Updates
7.5.6 The Menarini Group Competitive Strengths & Weaknesses
7.6 Bio-Rad Laboratories Inc.
7.6.1 Bio-Rad Laboratories Inc. Details
7.6.2 Bio-Rad Laboratories Inc. Major Business
7.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.6.4 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bio-Rad Laboratories Inc. Recent Developments/Updates
7.6.6 Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
7.7 QIAGEN Inc.
7.7.1 QIAGEN Inc. Details
7.7.2 QIAGEN Inc. Major Business
7.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.7.4 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 QIAGEN Inc. Recent Developments/Updates
7.7.6 QIAGEN Inc. Competitive Strengths & Weaknesses
7.8 Exact Sciences Corporation
7.8.1 Exact Sciences Corporation Details
7.8.2 Exact Sciences Corporation Major Business
7.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
7.8.4 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Exact Sciences Corporation Recent Developments/Updates
7.8.6 Exact Sciences Corporation Competitive Strengths & Weaknesses
7.9 Bio-Techne Corporation
7.9.1 Bio-Techne Corporation Details
7.9.2 Bio-Techne Corporation Major Business
7.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
7.9.4 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio-Techne Corporation Recent Developments/Updates
7.9.6 Bio-Techne Corporation Competitive Strengths & Weaknesses
7.10 ArcherDX Inc.
7.10.1 ArcherDX Inc. Details
7.10.2 ArcherDX Inc. Major Business
7.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.10.4 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ArcherDX Inc. Recent Developments/Updates
7.10.6 ArcherDX Inc. Competitive Strengths & Weaknesses
7.11 Neogenomics Laboratories Inc.
7.11.1 Neogenomics Laboratories Inc. Details
7.11.2 Neogenomics Laboratories Inc. Major Business
7.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.11.4 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Neogenomics Laboratories Inc. Recent Developments/Updates
7.11.6 Neogenomics Laboratories Inc. Competitive Strengths & Weaknesses
7.12 Guardant Health Inc.
7.12.1 Guardant Health Inc. Details
7.12.2 Guardant Health Inc. Major Business
7.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.12.4 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Guardant Health Inc. Recent Developments/Updates
7.12.6 Guardant Health Inc. Competitive Strengths & Weaknesses
7.13 Myriad Genetics Inc.
7.13.1 Myriad Genetics Inc. Details
7.13.2 Myriad Genetics Inc. Major Business
7.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.13.4 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Myriad Genetics Inc. Recent Developments/Updates
7.13.6 Myriad Genetics Inc. Competitive Strengths & Weaknesses
7.14 Foundation Medicine Inc.
7.14.1 Foundation Medicine Inc. Details
7.14.2 Foundation Medicine Inc. Major Business
7.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.14.4 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Foundation Medicine Inc. Recent Developments/Updates
7.14.6 Foundation Medicine Inc. Competitive Strengths & Weaknesses
7.15 Amoy Diagnostics Co. Ltd.
7.15.1 Amoy Diagnostics Co. Ltd. Details
7.15.2 Amoy Diagnostics Co. Ltd. Major Business
7.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
7.15.4 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amoy Diagnostics Co. Ltd. Recent Developments/Updates
7.15.6 Amoy Diagnostics Co. Ltd. Competitive Strengths & Weaknesses
7.16 Biocartis Group NV
7.16.1 Biocartis Group NV Details
7.16.2 Biocartis Group NV Major Business
7.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Services
7.16.4 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Biocartis Group NV Recent Developments/Updates
7.16.6 Biocartis Group NV Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Liquid Biopsy For Cancer Diagnostics Industry Chain
8.2 Liquid Biopsy For Cancer Diagnostics Upstream Analysis
8.3 Liquid Biopsy For Cancer Diagnostics Midstream Analysis
8.4 Liquid Biopsy For Cancer Diagnostics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Liquid Biopsy For Cancer Diagnostics Introduction
1.2 World Liquid Biopsy For Cancer Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Liquid Biopsy For Cancer Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.3 China Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.4 Europe Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.5 Japan Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.6 South Korea Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.7 ASEAN Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.3.8 India Liquid Biopsy For Cancer Diagnostics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liquid Biopsy For Cancer Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Liquid Biopsy For Cancer Diagnostics Major Market Trends
2 DEMAND SUMMARY
2.1 World Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.2 World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region
2.2.1 World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023)
2.2.2 World Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Region (2024-2029)
2.3 United States Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.4 China Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.5 Europe Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.6 Japan Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.7 South Korea Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.8 ASEAN Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
2.9 India Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029)
3 WORLD LIQUID BIOPSY FOR CANCER DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Liquid Biopsy For Cancer Diagnostics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liquid Biopsy For Cancer Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liquid Biopsy For Cancer Diagnostics in 2022
3.2.3 Global Concentration Ratios (CR8) for Liquid Biopsy For Cancer Diagnostics in 2022
3.3 Liquid Biopsy For Cancer Diagnostics Company Evaluation Quadrant
3.4 Liquid Biopsy For Cancer Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Liquid Biopsy For Cancer Diagnostics Market: Region Footprint
3.4.2 Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
3.4.3 Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Liquid Biopsy For Cancer Diagnostics Companies and Market Share, 2018-2023
4.3.1 United States Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
4.4 China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue and Market Share, 2018-2023
4.4.1 China Based Liquid Biopsy For Cancer Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
4.5 Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Liquid Biopsy For Cancer Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Test
5.2.2 Urine Test
5.2.3 Saliva Test
5.3 Market Segment by Type
5.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2018-2023)
5.3.2 World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2024-2029)
5.3.3 World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Liquid Biopsy For Cancer Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2023)
6.3.2 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffman La Roche Ltd.
7.1.1 F. Hoffman La Roche Ltd. Details
7.1.2 F. Hoffman La Roche Ltd. Major Business
7.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
7.1.4 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffman La Roche Ltd. Recent Developments/Updates
7.1.6 F. Hoffman La Roche Ltd. Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Details
7.2.2 Thermo Fisher Scientific Inc. Major Business
7.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.2.4 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.3 Agilent Technologies Inc.
7.3.1 Agilent Technologies Inc. Details
7.3.2 Agilent Technologies Inc. Major Business
7.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Agilent Technologies Inc. Recent Developments/Updates
7.3.6 Agilent Technologies Inc. Competitive Strengths & Weaknesses
7.4 Illumina Inc.
7.4.1 Illumina Inc. Details
7.4.2 Illumina Inc. Major Business
7.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.4.4 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Illumina Inc. Recent Developments/Updates
7.4.6 Illumina Inc. Competitive Strengths & Weaknesses
7.5 The Menarini Group
7.5.1 The Menarini Group Details
7.5.2 The Menarini Group Major Business
7.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Services
7.5.4 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 The Menarini Group Recent Developments/Updates
7.5.6 The Menarini Group Competitive Strengths & Weaknesses
7.6 Bio-Rad Laboratories Inc.
7.6.1 Bio-Rad Laboratories Inc. Details
7.6.2 Bio-Rad Laboratories Inc. Major Business
7.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.6.4 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bio-Rad Laboratories Inc. Recent Developments/Updates
7.6.6 Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
7.7 QIAGEN Inc.
7.7.1 QIAGEN Inc. Details
7.7.2 QIAGEN Inc. Major Business
7.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.7.4 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 QIAGEN Inc. Recent Developments/Updates
7.7.6 QIAGEN Inc. Competitive Strengths & Weaknesses
7.8 Exact Sciences Corporation
7.8.1 Exact Sciences Corporation Details
7.8.2 Exact Sciences Corporation Major Business
7.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
7.8.4 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Exact Sciences Corporation Recent Developments/Updates
7.8.6 Exact Sciences Corporation Competitive Strengths & Weaknesses
7.9 Bio-Techne Corporation
7.9.1 Bio-Techne Corporation Details
7.9.2 Bio-Techne Corporation Major Business
7.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
7.9.4 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio-Techne Corporation Recent Developments/Updates
7.9.6 Bio-Techne Corporation Competitive Strengths & Weaknesses
7.10 ArcherDX Inc.
7.10.1 ArcherDX Inc. Details
7.10.2 ArcherDX Inc. Major Business
7.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.10.4 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ArcherDX Inc. Recent Developments/Updates
7.10.6 ArcherDX Inc. Competitive Strengths & Weaknesses
7.11 Neogenomics Laboratories Inc.
7.11.1 Neogenomics Laboratories Inc. Details
7.11.2 Neogenomics Laboratories Inc. Major Business
7.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.11.4 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Neogenomics Laboratories Inc. Recent Developments/Updates
7.11.6 Neogenomics Laboratories Inc. Competitive Strengths & Weaknesses
7.12 Guardant Health Inc.
7.12.1 Guardant Health Inc. Details
7.12.2 Guardant Health Inc. Major Business
7.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.12.4 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Guardant Health Inc. Recent Developments/Updates
7.12.6 Guardant Health Inc. Competitive Strengths & Weaknesses
7.13 Myriad Genetics Inc.
7.13.1 Myriad Genetics Inc. Details
7.13.2 Myriad Genetics Inc. Major Business
7.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.13.4 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Myriad Genetics Inc. Recent Developments/Updates
7.13.6 Myriad Genetics Inc. Competitive Strengths & Weaknesses
7.14 Foundation Medicine Inc.
7.14.1 Foundation Medicine Inc. Details
7.14.2 Foundation Medicine Inc. Major Business
7.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
7.14.4 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Foundation Medicine Inc. Recent Developments/Updates
7.14.6 Foundation Medicine Inc. Competitive Strengths & Weaknesses
7.15 Amoy Diagnostics Co. Ltd.
7.15.1 Amoy Diagnostics Co. Ltd. Details
7.15.2 Amoy Diagnostics Co. Ltd. Major Business
7.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
7.15.4 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amoy Diagnostics Co. Ltd. Recent Developments/Updates
7.15.6 Amoy Diagnostics Co. Ltd. Competitive Strengths & Weaknesses
7.16 Biocartis Group NV
7.16.1 Biocartis Group NV Details
7.16.2 Biocartis Group NV Major Business
7.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Services
7.16.4 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Biocartis Group NV Recent Developments/Updates
7.16.6 Biocartis Group NV Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Liquid Biopsy For Cancer Diagnostics Industry Chain
8.2 Liquid Biopsy For Cancer Diagnostics Upstream Analysis
8.3 Liquid Biopsy For Cancer Diagnostics Midstream Analysis
8.4 Liquid Biopsy For Cancer Diagnostics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy For Cancer Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Liquid Biopsy For Cancer Diagnostics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy For Cancer Diagnostics Players in 2022
Table 12. World Liquid Biopsy For Cancer Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Liquid Biopsy For Cancer Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy For Cancer Diagnostics Player
Table 15. Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
Table 16. Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
Table 17. Liquid Biopsy For Cancer Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy For Cancer Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 23. China Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 29. World Liquid Biopsy For Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Liquid Biopsy For Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2024-2029) & (USD Million)
Table 35. F. Hoffman La Roche Ltd. Basic Information, Area Served and Competitors
Table 36. F. Hoffman La Roche Ltd. Major Business
Table 37. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 38. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. F. Hoffman La Roche Ltd. Recent Developments/Updates
Table 40. F. Hoffman La Roche Ltd. Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Inc. Major Business
Table 43. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 44. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 46. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Inc. Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Inc. Major Business
Table 49. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 50. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Agilent Technologies Inc. Recent Developments/Updates
Table 52. Agilent Technologies Inc. Competitive Strengths & Weaknesses
Table 53. Illumina Inc. Basic Information, Area Served and Competitors
Table 54. Illumina Inc. Major Business
Table 55. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 56. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Illumina Inc. Recent Developments/Updates
Table 58. Illumina Inc. Competitive Strengths & Weaknesses
Table 59. The Menarini Group Basic Information, Area Served and Competitors
Table 60. The Menarini Group Major Business
Table 61. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Services
Table 62. The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. The Menarini Group Recent Developments/Updates
Table 64. The Menarini Group Competitive Strengths & Weaknesses
Table 65. Bio-Rad Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Bio-Rad Laboratories Inc. Major Business
Table 67. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 68. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bio-Rad Laboratories Inc. Recent Developments/Updates
Table 70. Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 71. QIAGEN Inc. Basic Information, Area Served and Competitors
Table 72. QIAGEN Inc. Major Business
Table 73. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 74. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. QIAGEN Inc. Recent Developments/Updates
Table 76. QIAGEN Inc. Competitive Strengths & Weaknesses
Table 77. Exact Sciences Corporation Basic Information, Area Served and Competitors
Table 78. Exact Sciences Corporation Major Business
Table 79. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
Table 80. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Exact Sciences Corporation Recent Developments/Updates
Table 82. Exact Sciences Corporation Competitive Strengths & Weaknesses
Table 83. Bio-Techne Corporation Basic Information, Area Served and Competitors
Table 84. Bio-Techne Corporation Major Business
Table 85. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
Table 86. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio-Techne Corporation Recent Developments/Updates
Table 88. Bio-Techne Corporation Competitive Strengths & Weaknesses
Table 89. ArcherDX Inc. Basic Information, Area Served and Competitors
Table 90. ArcherDX Inc. Major Business
Table 91. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 92. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. ArcherDX Inc. Recent Developments/Updates
Table 94. ArcherDX Inc. Competitive Strengths & Weaknesses
Table 95. Neogenomics Laboratories Inc. Basic Information, Area Served and Competitors
Table 96. Neogenomics Laboratories Inc. Major Business
Table 97. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 98. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Neogenomics Laboratories Inc. Recent Developments/Updates
Table 100. Neogenomics Laboratories Inc. Competitive Strengths & Weaknesses
Table 101. Guardant Health Inc. Basic Information, Area Served and Competitors
Table 102. Guardant Health Inc. Major Business
Table 103. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 104. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Guardant Health Inc. Recent Developments/Updates
Table 106. Guardant Health Inc. Competitive Strengths & Weaknesses
Table 107. Myriad Genetics Inc. Basic Information, Area Served and Competitors
Table 108. Myriad Genetics Inc. Major Business
Table 109. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 110. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Myriad Genetics Inc. Recent Developments/Updates
Table 112. Myriad Genetics Inc. Competitive Strengths & Weaknesses
Table 113. Foundation Medicine Inc. Basic Information, Area Served and Competitors
Table 114. Foundation Medicine Inc. Major Business
Table 115. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 116. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Foundation Medicine Inc. Recent Developments/Updates
Table 118. Foundation Medicine Inc. Competitive Strengths & Weaknesses
Table 119. Amoy Diagnostics Co. Ltd. Basic Information, Area Served and Competitors
Table 120. Amoy Diagnostics Co. Ltd. Major Business
Table 121. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 122. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amoy Diagnostics Co. Ltd. Recent Developments/Updates
Table 124. Biocartis Group NV Basic Information, Area Served and Competitors
Table 125. Biocartis Group NV Major Business
Table 126. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Services
Table 127. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Liquid Biopsy For Cancer Diagnostics Upstream (Raw Materials)
Table 129. Liquid Biopsy For Cancer Diagnostics Typical Customers
LIST OF FIGURE
Figure 1. Liquid Biopsy For Cancer Diagnostics Picture
Figure 2. World Liquid Biopsy For Cancer Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Liquid Biopsy For Cancer Diagnostics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 13. Liquid Biopsy For Cancer Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy For Cancer Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy For Cancer Diagnostics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy For Cancer Diagnostics Markets in 2022
Figure 27. United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Liquid Biopsy For Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type in 2022
Figure 31. Blood Test
Figure 32. Urine Test
Figure 33. Saliva Test
Figure 34. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2018-2029)
Figure 35. World Liquid Biopsy For Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Diagnostic Center
Figure 39. Others
Figure 40. Liquid Biopsy For Cancer Diagnostics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Liquid Biopsy For Cancer Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liquid Biopsy For Cancer Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Liquid Biopsy For Cancer Diagnostics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Liquid Biopsy For Cancer Diagnostics Players in 2022
Table 12. World Liquid Biopsy For Cancer Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Liquid Biopsy For Cancer Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Liquid Biopsy For Cancer Diagnostics Player
Table 15. Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
Table 16. Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
Table 17. Liquid Biopsy For Cancer Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Liquid Biopsy For Cancer Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Liquid Biopsy For Cancer Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 23. China Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Liquid Biopsy For Cancer Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Liquid Biopsy For Cancer Diagnostics Revenue Market Share (2018-2023)
Table 29. World Liquid Biopsy For Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Liquid Biopsy For Cancer Diagnostics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Liquid Biopsy For Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Liquid Biopsy For Cancer Diagnostics Market Size by Application (2024-2029) & (USD Million)
Table 35. F. Hoffman La Roche Ltd. Basic Information, Area Served and Competitors
Table 36. F. Hoffman La Roche Ltd. Major Business
Table 37. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 38. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. F. Hoffman La Roche Ltd. Recent Developments/Updates
Table 40. F. Hoffman La Roche Ltd. Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Inc. Major Business
Table 43. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 44. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 46. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Inc. Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Inc. Major Business
Table 49. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 50. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Agilent Technologies Inc. Recent Developments/Updates
Table 52. Agilent Technologies Inc. Competitive Strengths & Weaknesses
Table 53. Illumina Inc. Basic Information, Area Served and Competitors
Table 54. Illumina Inc. Major Business
Table 55. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 56. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Illumina Inc. Recent Developments/Updates
Table 58. Illumina Inc. Competitive Strengths & Weaknesses
Table 59. The Menarini Group Basic Information, Area Served and Competitors
Table 60. The Menarini Group Major Business
Table 61. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Services
Table 62. The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. The Menarini Group Recent Developments/Updates
Table 64. The Menarini Group Competitive Strengths & Weaknesses
Table 65. Bio-Rad Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Bio-Rad Laboratories Inc. Major Business
Table 67. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 68. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bio-Rad Laboratories Inc. Recent Developments/Updates
Table 70. Bio-Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 71. QIAGEN Inc. Basic Information, Area Served and Competitors
Table 72. QIAGEN Inc. Major Business
Table 73. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 74. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. QIAGEN Inc. Recent Developments/Updates
Table 76. QIAGEN Inc. Competitive Strengths & Weaknesses
Table 77. Exact Sciences Corporation Basic Information, Area Served and Competitors
Table 78. Exact Sciences Corporation Major Business
Table 79. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
Table 80. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Exact Sciences Corporation Recent Developments/Updates
Table 82. Exact Sciences Corporation Competitive Strengths & Weaknesses
Table 83. Bio-Techne Corporation Basic Information, Area Served and Competitors
Table 84. Bio-Techne Corporation Major Business
Table 85. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Services
Table 86. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio-Techne Corporation Recent Developments/Updates
Table 88. Bio-Techne Corporation Competitive Strengths & Weaknesses
Table 89. ArcherDX Inc. Basic Information, Area Served and Competitors
Table 90. ArcherDX Inc. Major Business
Table 91. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 92. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. ArcherDX Inc. Recent Developments/Updates
Table 94. ArcherDX Inc. Competitive Strengths & Weaknesses
Table 95. Neogenomics Laboratories Inc. Basic Information, Area Served and Competitors
Table 96. Neogenomics Laboratories Inc. Major Business
Table 97. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 98. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Neogenomics Laboratories Inc. Recent Developments/Updates
Table 100. Neogenomics Laboratories Inc. Competitive Strengths & Weaknesses
Table 101. Guardant Health Inc. Basic Information, Area Served and Competitors
Table 102. Guardant Health Inc. Major Business
Table 103. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 104. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Guardant Health Inc. Recent Developments/Updates
Table 106. Guardant Health Inc. Competitive Strengths & Weaknesses
Table 107. Myriad Genetics Inc. Basic Information, Area Served and Competitors
Table 108. Myriad Genetics Inc. Major Business
Table 109. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 110. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Myriad Genetics Inc. Recent Developments/Updates
Table 112. Myriad Genetics Inc. Competitive Strengths & Weaknesses
Table 113. Foundation Medicine Inc. Basic Information, Area Served and Competitors
Table 114. Foundation Medicine Inc. Major Business
Table 115. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 116. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Foundation Medicine Inc. Recent Developments/Updates
Table 118. Foundation Medicine Inc. Competitive Strengths & Weaknesses
Table 119. Amoy Diagnostics Co. Ltd. Basic Information, Area Served and Competitors
Table 120. Amoy Diagnostics Co. Ltd. Major Business
Table 121. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Services
Table 122. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amoy Diagnostics Co. Ltd. Recent Developments/Updates
Table 124. Biocartis Group NV Basic Information, Area Served and Competitors
Table 125. Biocartis Group NV Major Business
Table 126. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Services
Table 127. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Liquid Biopsy For Cancer Diagnostics Upstream (Raw Materials)
Table 129. Liquid Biopsy For Cancer Diagnostics Typical Customers
LIST OF FIGURE
Figure 1. Liquid Biopsy For Cancer Diagnostics Picture
Figure 2. World Liquid Biopsy For Cancer Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Liquid Biopsy For Cancer Diagnostics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Liquid Biopsy For Cancer Diagnostics Revenue (2018-2029) & (USD Million)
Figure 13. Liquid Biopsy For Cancer Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Liquid Biopsy For Cancer Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liquid Biopsy For Cancer Diagnostics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liquid Biopsy For Cancer Diagnostics Markets in 2022
Figure 27. United States VS China: Liquid Biopsy For Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Liquid Biopsy For Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type in 2022
Figure 31. Blood Test
Figure 32. Urine Test
Figure 33. Saliva Test
Figure 34. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2018-2029)
Figure 35. World Liquid Biopsy For Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Diagnostic Center
Figure 39. Others
Figure 40. Liquid Biopsy For Cancer Diagnostics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
